1256386-53-4

Upstream product

• 1007881-98-2 y 
• 7644-04-4 4-bromophenacylamine 
• 15761-39-4 1-(tert-butoxycarbonyl)-L-proline 
• 1007882-04-3 (S)-tert-butyl 2-(5-(4-bromophenyl)-1H-imidazol-2-yl)pyrrolidine-1-carboxylate 
• 76513-69-4 (2-trimethylethylsilylethoxy)methyl chloride 

Downstream Products

• 1256386-52-3 C₄₇H₇₇N₇O₆Si₂ 
• 1265681-80-8 C₄₄H₆₈N₆O₆Si₂ 

Relevant academic research and scientific papers

Phenyl Ethynyl Derivatives As Hepatitis C Virus Inhibitors

Inhibitors of HCV replication of formula I including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein R and R* have the meaning defined in the claims. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HCV inhibitors, in the treatment or prophylaxis of HCV.

PHENYL ETHYNYL DERIVATIVES AS HEPATITIS C VIRUS INHIBITORS

Inhibitors of HCV replication of Formula (I) including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein R and R* have the meaning defined in the claims. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HCV inhibitors, in the treatment or prophylaxis of HCV.